array-based-gene-expression-in-neuroblastic-tumors23cancercellintermediatenervous systemneuroblastomahumanFalseE-GEOD-181393413Array-based gene expression in neuroblastic tumorsezh2-over-expression-is-associated-with-gain-of-ch49cancercellchromosomeneuroblastomahumanFalseE-GEOD-284094028EZH2 over-expression is associated with gain of chromosome arm 7q and essential for cell cycle progression and a marker of poor prognosis in neuroblastomafoxo3a-is-a-major-target-of-inactivation-by-pi3kak212cellnervous systemneuroblastomaperipheralsympathetic nervous systemhumanFalseE-GEOD-427622452FOXO3a Is A Major Target Of Inactivation By PI3K/AKT Signaling In Aggressive Neuroblastomaexpression-array-of-peripheral-neuro-ectodermal-ce422actincancercellectodermal cellneuroblastomaperipheraltyrosinehumanFalseE-GEOD-339034318Expression array of peripheral neuro-ectodermal cell linesa-genome-wide-methylation-map-of-neuroblastoma-cel216cellneuroblastomahumanFalseE-GEOD-313554201A genome wide methylation map of neuroblastoma cell linesanalysis-of-tale-homeobox-genes-in-neuroblastic-2327ganglioneuroblastomaganglioneuromaneuroblastomahumanFalseE-GEOD-182723429Analysis of TALE homeobox genes in neuroblastic tumors and Cell linesanalysis-of-tale-homeobox-genes-in-neuroblastic-tu122amino acidcellclassdiseaseganglioneuroblastomaganglioneuromaneuroblastomahumanFalseE-GEOD-182713428Analysis of TALE homeobox genes in neuroblastic tumors: ganglioneuroblastoma and ganglioneuromaanaplastic-lymphoma-kinase-alk-inhibitor-response417celllymphomaneuroblastomapointproteinhumanFalseE-GEOD-227713732Anaplastic lymphoma kinase (ALK) inhibitor response in neuroblastoma is highly correlated with ALK mutation status, ALK mRNA and protein levels.inactivation-of-cdk2-is-synthetic-lethal-to-mycn-o015cancercelllineneuroblastomahumanFalseE-GEOD-164802022Inactivation of CDK2 is synthetic lethal to MYCN-overexpressing cancer cellsintegrated-bioinformatic-and-wet-lab-approach-to-3088cellneuroblastomanotchhumanFalseE-GEOD-164763311Integrated bioinformatic and wet-lab approach to identify potential oncogenic networks in neuroblastoma